Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LHC165 |
Trade Name | |
Synonyms | LHC-165 |
Drug Descriptions |
LHC165 is an agonist to the toll like receptor 7 (TLR7), combined with aluminum hydroxide for slow release, to activate the immune system (AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4128). |
DrugClasses | TLR7 Agonist 12 |
CAS Registry Number | 1258595-14-0 |
NCIT ID | C166362 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LHC165 | LHC165 | 0 | 1 |
LHC165 + Spartalizumab | LHC165 Spartalizumab | 0 | 1 |